These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32576731)

  • 1. Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy.
    Morris SE; Dziobek-Garrett L; Strehlau R; Schröter J; Shiau S; Anelone AJN; Paximadis M; de Boer RJ; Abrams EJ; Tiemessen CT; Kuhn L; Yates AJ;
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):209-218. PubMed ID: 32576731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to Viral Suppression in Perinatally HIV-Infected Infants Depends on the Viral Load and CD4 T-Cell Percentage at the Start of Treatment.
    Schröter J; Anelone AJN; Yates AJ; de Boer RJ;
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):522-529. PubMed ID: 31917752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Pretreatment Viral Loads in Infants With HIV in an Era of High-maternal Antiretroviral Therapy Coverage.
    Patel F; Shiau S; Strehlau R; Shen Y; Burke M; Paximadis M; Shalekoff S; Schramm D; Technau KG; Sherman GG; Coovadia A; Tiemessen CT; Abrams EJ; Kuhn L
    Pediatr Infect Dis J; 2021 Jan; 40(1):55-59. PubMed ID: 32925542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthy dynamics of CD4 T cells may drive HIV resurgence in perinatally-infected infants on antiretroviral therapy.
    Morris SE; Strehlau R; Shiau S; Abrams EJ; Tiemessen CT; Kuhn L; Yates AJ;
    PLoS Pathog; 2022 Aug; 18(8):e1010751. PubMed ID: 35969641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women.
    Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Mthiko BC; Phulusa J; John M; Jumbe A; Hosseinipour MC
    PLoS One; 2018; 13(4):e0195033. PubMed ID: 29614083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
    Frange P; Faye A; Avettand-Fenoël V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; Sáez-Cirión A;
    Lancet HIV; 2016 Jan; 3(1):e49-54. PubMed ID: 26762993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing Viral Load Burden Among HIV-Infected Women Around the Time of Delivery: Findings From Four Tertiary Obstetric Units in Gauteng, South Africa.
    Moyo F; Haeri Mazanderani A; Murray T; Technau KG; Carmona S; Kufa T; Sherman GG
    J Acquir Immune Defic Syndr; 2020 Apr; 83(4):390-396. PubMed ID: 31914002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.
    Myer L; Phillips TK; Hsiao NY; Zerbe A; Petro G; Bekker LG; McIntyre JA; Abrams EJ
    J Int AIDS Soc; 2015; 18(1):20045. PubMed ID: 26154734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants.
    Kuhn L; Paximadis M; Da Costa Dias B; Shen Y; Mncube S; Strehlau R; Shiau S; Patel F; Burke M; Technau KG; Sherman G; Loubser S; Abrams EJ; Tiemessen CT
    Clin Infect Dis; 2022 Mar; 74(6):1047-1054. PubMed ID: 34185838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
    Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
    J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children.
    Tagarro A; Chan M; Zangari P; Ferns B; Foster C; De Rossi A; Nastouli E; Muñoz-Fernández MA; Gibb D; Rossi P; Giaquinto C; Babiker A; Fortuny C; Freguja R; Cotugno N; Judd A; Noguera-Julian A; Navarro ML; Mellado MJ; Klein N; Palma P; Rojo P
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):269-276. PubMed ID: 30211778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
    Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam.
    Pham HV; Ishizaki A; Nguyen LV; Phan CT; Phung TT; Takemoto K; Pham AN; Bi X; Khu DT; Ichimura H
    Int J STD AIDS; 2015 Oct; 26(11):821-30. PubMed ID: 25332224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.
    Mphatswe W; Blanckenberg N; Tudor-Williams G; Prendergast A; Thobakgale C; Mkhwanazi N; McCarthy N; Walker BD; Kiepiela P; Goulder P
    AIDS; 2007 Jun; 21(10):1253-61. PubMed ID: 17545701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.
    Siberry GK; Patel K; Van Dyke RB; Hazra R; Burchett SK; Spector SA; Paul ME; Read JS; Wiznia A; Seage GR;
    J Acquir Immune Defic Syndr; 2011 Jul; 57(3):223-9. PubMed ID: 21423022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
    Hunt PW; Cao HL; Muzoora C; Ssewanyana I; Bennett J; Emenyonu N; Kembabazi A; Neilands TB; Bangsberg DR; Deeks SG; Martin JN
    AIDS; 2011 Nov; 25(17):2123-31. PubMed ID: 21881481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.